Key result
Hemodialysis was associated with a significantly higher risk of congestive heart failure-related hospitalization compared with peritoneal dialysis (HR 1.45).
Why the study?
Determining which dialysis modality carries a higher risk of congestive heart failure could facilitate clinical decision-making and surveillance programs.
Does hemodialysis increase the risk of congestive heart failure-related hospitalizations compared to peritoneal dialysis in incident ESRD patients?
Cohort (n=65,899)
Does hemodialysis increase the risk of congestive heart failure-related hospitalizations compared to peritoneal dialysis in incident ESRD patients?
Hazard Ratio: 1.45 (95% CI 1.23–1.7)
Absolute Event Rate: 25.98% vs 19.71%
p-value: p=<0.001
In incident end-stage renal disease patients, hemodialysis is associated with a significantly higher risk of congestive heart failure-related hospitalization compared to peritoneal dialysis.
May favor PD over HD to lower CHF hospitalization risk in incident ESRD; leaves open causal confirmation by RCTs.
INTRODUCTION: Congestive heart failure (CHF) is associated with high mortality and a heavy financial and healthcare burden in the dialysis population. Determining which dialysis modality is associated with a higher risk of developing CHF might facilitate clinical decision making and surveillance programs in the dialysis population. METHODS: Using the Taiwan National Health Insurance Database, we recruited all incident dialysis patients during the period from January 1, 1998 to December 31, 2010. The propensity score matching method was applied to establish the matched hemodialysis (HD) and peritoneal dialysis (PD) cohort. Incidence rates and cumulative incidence rates of CHF-related hospitalization were first compared for the HD and PD patients. Multivariable subdistribution hazards models were then constructed to control for potential confounders. RESULTS: Among a total of 65,899 enrolled dialysis patients, 4,754 matched pairs of HD and PD patients were identified. The incidence rates of CHF in the matched HD and PD patients were 25.98 and 19.71 per 1000 patient-years, respectively (P = 0.001). The cumulative incidence rate of CHF was also higher in the matched HD patients (0.16, 95% confidence interval (CI)(0.12-0.21)] than in the corresponding PD patients (0.09, 95% CI [0.08-0.11])(P<0.0001). HD was consistently associated with an increased subdistribution hazard ratio (HR) of CHF compared with PD in the matched cohort (HR: 1.45, 95% CI [1.23-1.7]). Similar phenomenons were observed in either the subgroup analysis stratified by selected confounders or in the HD and PD group without matching. CONCLUSIONS: HD is associated with a higher risk of developing CHF-related hospitalization than PD. The surveillance program for CHF should differ in patients receiving different dialysis modalities.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2019) conducted a cohort in End-stage renal disease (ESRD) (n=65,899). Hemodialysis vs. Peritoneal dialysis was evaluated on Congestive heart failure (CHF)-related hospitalization (HR 1.45, 95% CI 1.23-1.70, p=<0.001). Hemodialysis was associated with a significantly higher risk of congestive heart failure-related hospitalization compared with peritoneal dialysis (HR 1.45).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: